Ivan Tornos
President, CEO & Chairman of the BoardMr. Ivan Tornos is President, CEO & Director of Zimmer Biomet Holdings, Inc. from August 2023 and serves as its Chairman of the Board from May 29, 2025. Mr. Tornos was COO, President, CEO & Director of Zimmer Biomet Holdings, Inc. from August 22, 2023 to May 29, 2025. Mr. Tornos was Chief Operating Officer of Zimmer Biomet Holdings, Inc. from March 2021 to August 22, 2023. Mr. Tornos was Group President of Global Businesses & The Americas of Zimmer Biomet Holdings, Inc. from December 2019 to March 2021. Mr. Tornos was Group President of Orthopedics of Zimmer Biomet Holdings, Inc. from November 01, 2018 to December 2019. Mr. Tornos joined the Zimmer Biomet Holdings, Inc. on November 01, 2018. Mr. Ivan Tornos serves as Independent External Director at PHC Holdings Corporation since September 03, 2021. He joined PHC Holdings Corporation on September 03, 2021. Mr. Tornos served as Chief Operating Officer at Zimmer Biomet Holdings, Inc. since March 2021 and serves as its President & CEO and Director since August 22, 2023. Mr. Tornos was Group President of Global Businesses and the Americas at Zimmer Biomet Holdings since December 2019 until March 2021. He served in various global roles for Fortune 50 to 500 companies. He joined the Zimmer Biomet Holdings, Inc. on November 01, 2018. Prior to joining Zimmer Biomet, he served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company since June 2017 until October 2018. From June 2017 until BD’s acquisition of Bard in December 2017. Mr. Tornos has been President of EMEA of Bard since September 2013. He joined Bard in August 2011. He served as Vice President and General Manager with leadership responsibility for Bard’s business in Southern Europe, Central Europe and the Emerging Markets Region of the Middle East and Africa. He served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging Segments of Covidien International since April 2009 until August 2011. He served as International Vice President, Business Development and Strategy with Baxter International Inc since July 2008 until April 2009. He worked with Johnson & Johnson in positions of increasing responsibility. He is an alumnus of the Harvard Business School having graduated from the Advanced Management Program (AMP 187) and also completed Leadership and Management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University Of Miami School Of Business and a BBA in Finance and International Marketing and Management from the University Of Georgia Terry College Of Business.
Positions
- Company NameZimmer Biomet Holdings, Inc.Stock CodeZBHPositionPresident, CEO & Chairman of the BoardColleagues
- JNJehanZeb NoorChief Strategy, Business Development, Innovation, Operations & Transformation Officer
- WVWilfred van ZuilenGroup President of Europe, Middle East & Africa
- PAPaul A. StellatoInterim CFO, VP, Controller & Chief Accounting Officer
- SBShaun BraunSenior VP & Chief Information and Technology Officer
- BJBetsy Jane BernardIndependent Director
- MTMaria Teresa HiladoIndependent Director
- SASyed A. JafryIndependent Director
- MJMichael J. FarrellLead Independent Director
